(Q33341929)

25 July 2017

title

Topiramate enhances the risk of valproate-associated side effects in three children (English)

1 reference

25 July 2017

Elke Longin

1

1 reference

25 July 2017

Martin Teich

series ordinal

2

1 reference

25 July 2017

W Koelfen

series ordinal

3

1 reference

25 July 2017

Stefan König

series ordinal

4

1 reference

25 July 2017

publication date

1 April 2002

1 reference

25 July 2017

1 reference

25 July 2017

volume

43

1 reference

25 July 2017

issue

4

1 reference

25 July 2017

page(s)

451-454

1 reference

Adverse effects of valproate.

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42401.X

Valproate treatment and platelet function: the role of arachidonate metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42401.X

Side effects of valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42401.X

Valproic acid hepatic fatalities. II. US experience since 1984.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42401.X

Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42401.X

Valproate-induced coma with ketosis and carnitine insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42401.X

Valproate-induced hyperammonemic encephalopathy in the presence of topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42401.X

Hematologic toxicity of sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.42401.X

10.1046/J.1528-1157.2002.42401.X

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference